← Open Payments lookup

LAUREN KYZAR: Open Payments

NPI 1215552021 · TUSCALOOSA, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$350 in 17 payments from 11 companies in 2025. Trend: 2023 $5,633 · 2024 $4,979 · 2025 $350

Food & beverage: $350
CompanyPaymentsAmount
ABBVIE INC.4$74
CSL Behring2$69
Neurocrine BioSciences, Inc.2$46
Axsome Therapeutics, Inc.2$31
Alexion Pharmaceuticals, Inc.1$29
Lilly USA, LLC1$20
ACADIA Pharmaceuticals Inc1$19
ARGENX US, INC.1$18
Amgen Inc.1$16
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)1$14

Products named: Hizentra, INGREZZA, VRAYLAR, ULTOMIRIS, UBRELVY, KISUNLA, NUPLAZID, Sunosi.

Industry payments across AL — which companies pay providers there.